Find uplifting stories about heroes, innovations, and solutions
1091 results for "shingles vaccine"
A new study of over 500,000 nursing home residents found that people who received the Shingrix shingles vaccine were 24% less likely to develop dementia. This common vaccine could prevent one in 17 dementia cases while also protecting against painful shingles infections.
A patient who got shingles despite vaccination experienced zero pain, proving the shot's protective power extends beyond prevention. Doctors confirm this bonus benefit could spare millions from agonizing nerve pain.
A common vaccine designed to prevent shingles may also protect against dementia and Alzheimer's disease. Multiple studies across three countries show vaccinated adults face significantly lower dementia rates.
A USC study of 3,800 older adults found that the shingles vaccine doesn't just prevent disease—it may actually slow biological aging. Vaccinated seniors showed lower inflammation and younger biological profiles than unvaccinated peers.
New research reveals the shingles vaccine does more than prevent painful rashes. Scientists found it may protect against dementia and slow biological aging at the molecular level.
Scientists have identified three medicines already on pharmacy shelves that could help fight Alzheimer's, with a shingles vaccine leading the pack. The discovery could fast-track new treatments by years and save billions in development costs.
A common vaccine given to seniors might do more than prevent shingles. Scientists found it could actually slow down biological aging and reduce the inflammation that drives age-related diseases.
A major study found that older adults who received the Shingrix vaccine had a 24% lower risk of developing dementia compared to those who didn't. The finding adds to growing evidence that protecting your brain health might be as simple as staying current on your vaccines.
Getting a shingles shot might do more than prevent a painful rash. New research shows it could actually slow down how fast your body ages.
The same technology that revolutionized COVID vaccines just earned approval for seasonal flu, potentially ending decades of hit-or-miss protection. Moderna's mRNA flu shot marks a new era in how we fight one of America's most common infectious diseases.
Since the HPV vaccine became available in 2006, cervical cancer rates have dropped 27% among young American women, with some states seeing reductions over 50%. Every 10% increase in vaccination rates translates to nearly 12% fewer cancer cases.
South Carolina's largest measles outbreak in decades has officially ended after nearly 1,000 cases, and there's encouraging news: vaccination rates are climbing both locally and nationwide. Health officials say the outbreak may have reminded parents why vaccines matter.
South Africa is preparing to roll out a groundbreaking tuberculosis vaccine for adults that could become the first new TB vaccine in over a century. The M72/AS01E vaccine is currently in Phase 3 trials across five countries and could help eliminate TB as a public health threat by 2030.
Scientists at Washington University have created a nose spray vaccine that completely protected mice and hamsters from bird flu infection, offering hope for preventing the next pandemic. The vaccine works better than traditional flu shots and stays effective even in people who've had previous flu vaccines.
The FDA reversed its decision and will now review Moderna's groundbreaking mRNA flu vaccine, marking a potential leap forward in flu prevention. This could bring the same technology that revolutionized COVID vaccines to seasonal flu shots.
California health officials are encouraging at-risk residents to get vaccinated against mpox as case rates have more than quadrupled compared to last year. The vaccine provides strong protection against both strains of the virus, and most new infections are happening in unvaccinated people.
A tetanus-diphtheria vaccine that stays effective for two years without refrigeration has passed its first human safety trial. The breakthrough could help vaccines reach millions in remote areas where keeping medicines cold is nearly impossible.
The same groundbreaking technology that created COVID vaccines just earned approval for fighting the flu. Moderna's new mRNA flu shot showed better protection than standard vaccines and will be available for the 2026-2027 flu season.
A groundbreaking trial shows Moderna's new mRNA flu vaccine is 27% more effective than traditional flu shots, offering hope for better protection during flu season. The technology's faster production could mean vaccines that better match circulating strains.
African countries have prevented nearly one million cervical cancer deaths through expanded HPV vaccination programs since 2019, while new malaria vaccines are saving thousands of children across 25 nations. These historic health wins are generating $1.8 billion in economic benefits, though funding gaps now threaten to slow the momentum.
Showing 20 of 1091